Boehringer backs €20B R&D game plan with a $272M blue­print for new fa­cil­i­ty — 100 new hires

Boehringer In­gel­heim is back­ing their bi­o­log­ics fo­cus in R&D with a $272 mil­lion in­vest­ment in a new fa­cil­i­ty that will add an­oth­er 100 staffers to the pay­roll.

The biotech com­pa­ny is adding a new de­vel­op­ment cen­ter in Bib­er­ach, Ger­many, which they plan to staff with 500 em­ploy­ees, in­clud­ing the new hires. The pri­vate com­pa­ny is plan­ning on a stag­gered open­ing in 2020, bring­ing in the 500 em­ploy­ees while look­ing to beef up its ca­pac­i­ty on “bi­o­log­i­cals an­a­lyt­i­cal and process de­vel­op­ment as well as man­u­fac­tur­ing for clin­i­cal stud­ies in­to one seam­less unit, while at the same time in­creas­ing de­vel­op­ment ca­pac­i­ty.”

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER